Beijing | Shanghai | Shenzhen | Hong Kong | SingaporeCompany Resourceswww.apvaluation.com
APA Consulting & Appraisal

Financial Advisory

Financial Advisory

Financial Advisory

In-depth financial due diligence (FDD), feasibility analysis reports (FAR) and related advisory services. We provide tailored decision support for investment and financing, strategic expansion and risk management.

Financial Advisory

Scope of ServicesScope of Services

09

Professional Advisory

  • Financial Due Diligence Reports
  • Feasibility Analysis Reports
  • Business Valuation for Tax Purposes
  • Shareholding Restructuring Plans

Selected Project ExperienceSelected Experience

View All →
No.CompanyIndustryListing InformationValuation Scope
1Londian WasonNew EnergyNYSE, 2026-08Equity valuation
2CrealityTMTHong Kong, 2026-05Share-based payments; property valuation
3LDRobotIndustrialHong Kong, 2026-05Enterprise value; share-based payments
4Haizhi TechnologyTMTHong Kong, 2026-02Fair value measurements
5Ribo Life SciencePharmaceuticalsHong Kong, 2026-01Property valuation
6Iluvatar CoreXTMTHong Kong, 2026-01Long-term equity investments; share-based payments
7Zhipu AITMTHong Kong, 2026-01Purchase price allocation; goodwill impairment testing; share-based payments
851WORLDTMTHong Kong, 2025-12Financial assets; preferred shares
9Guoxia TechnologyTMTHong Kong, 2025-12Share-based payments
10JD IndustrialsIndustrialHong Kong, 2025-12Financial assets
11BiocytogenPharmaceuticalsSSE STAR Market, 2025-12Biological assets
12Moore ThreadsTMTSSE STAR Market, 2025-12Shareholding restructuring; share-based payments; financial assets
13Jinyan Kaolin New MaterialsEnergyHong Kong, 2025-12Property valuation
14SERESAutomotiveHong Kong, 2025-11Expected credit losses; long-term equity investments; employee options
15SICCTMTHong Kong, 2025-08Property valuation
16YimutianTMTNasdaq, 2025-08Convertible bonds; employee options; equity valuation
17HEC PharmPharmaceuticalsHong Kong, 2025-08Property valuation
18Youlan InternationalEducationNasdaq, 2025-07Purchase price allocation; goodwill impairment testing; preferred shares
19UnisoundTMTHong Kong, 2025-06Employee options; preferred shares; long-term equity investments
20TransTheraPharmaceuticalsHong Kong, 2025-06Equity incentives; equity valuation; intangible assets
21Baize MedicalHealthcareHong Kong, 2025-06PPA; goodwill impairment testing
22Shouhui GroupTMTHong Kong, 2025-05Preferred shares; employee options
23MirxesMedical DevicesHong Kong, 2025-05Purchase price allocation; goodwill impairment testing
24Green TeaFood & BeverageHong Kong, 2025-05Valuation for tax reporting
25Auntea JennyConsumer GoodsHong Kong, 2025-05Employee options; incremental borrowing rate; long-term equity investments
26CHAGEEConsumer GoodsNasdaq, 2025-04Share-based payments; equity valuation
27New Gonow Recreational VehiclesAutomotiveHong Kong, 2025-01Share-based payments
28Biostar PharmaPharmaceuticalsHong Kong, 2024-10Property valuation
29Horizon RoboticsTMTHong Kong, 2024-10Preferred shares; convertible bonds; warrants; long-term equity investments
30BaiwangTMTHong Kong, 2024-06Warrants; purchase price allocation; preferred shares
31DidaTMTHong Kong, 2024-06Preferred shares; employee options; convertible bonds
32Easou TechnologyTMTHong Kong, 2024-06Preferred shares; employee options
33ZEEKRAutomotiveNYSE, 2024-05Preferred shares; restricted stock
34Qyuns TherapeuticsPharmaceuticalsHong Kong, 2024-03Preferred shares; options
35Concord HealthcareHealthcareHong Kong, 2024-01Impairment testing; expected credit losses; convertible bonds
36Lancang Ancient TeaConsumer GoodsHong Kong, 2023-12Inventory
37Shiyue DaotianConsumer GoodsHong Kong, 2023-10Financial liabilities
38ZX Inc.TMTHong Kong, 2023-09Purchase price allocation; share-based payments; impairment testing of long-term investments
39Tuhu CarTMTHong Kong, 2023-09Purchase price allocation; share-based payments; equity valuation
40ZJLD GroupConsumer GoodsHong Kong, 2023-04Equity value
41Kang Le Wei ShiPharmaceuticalsBeijing Stock Exchange, 2023-03Share-based payments; value testing
42FenbiEducationHong Kong, 2023-01Preferred shares; employee options
43Super Hi InternationalFood & BeverageHong Kong, 2022-12Asset disposals
44ECARXTMTNasdaq, 2022-12Share-based payments; warrants; equity valuation
45Gaush MeditechHealthcareHong Kong, 2022-12Purchase price allocation; convertible bonds; preferred shares; guarantee rights
46Flowing CloudTMTHong Kong, 2022-10Preferred shares; equity valuation
47BiocytogenBiopharmaceuticalsHong Kong, 2022-09Employee options; biological assets; enterprise value
48LongsysTMTShenzhen Stock Exchange, 2022-05Equity valuation
49RainmedHealthcare (Medical Devices)Hong Kong, 2022-07Preferred shares; employee options; enterprise value
50SANY Renewable EnergyWind PowerSSE STAR Market, 2022-06Purchase price allocation
51ZhihuTMTHong Kong, 2022-04Employee options; preferred shares
52UJU HoldingTMTHong Kong, 2021-11Employee options; enterprise valuation
53Acotec ScientificHealthcare (Medical Devices)Hong Kong, 2021-08Equity valuation; purchase price allocation; employee options; preferred shares
54Chaoju Eye CareHealthcare (Ophthalmology)Hong Kong, 2021-07Equity valuation; purchase price allocation; goodwill impairment testing; share-based payments
55JD LogisticsTMTHong Kong, 2021-05Equity valuation; purchase price allocation
56BairongTMTHong Kong, 2021-03Equity valuation; preferred equity valuation; employee options
57ZhihuTMTNYSE, 2021-03Preferred equity valuation; employee options
58First High-School EducationEducationNYSE, 2021-03Purchase price allocation; employee options; leased properties; goodwill impairment testing
59Cheerwin GroupConsumer GoodsHong Kong, 2021-03Enterprise valuation for tax purposes
60KuaishouTMTHong Kong, 2021-02-05Available-for-sale financial assets
61Kuke MusicTMTNYSE, 2021-01Preferred shares; share-based payments
62Jacobio PharmaceuticalsPharmaceuticalsHong Kong, 2020-12Equity valuation; preferred equity valuation; employee options
63Jinhui HoldingsReal EstateHong Kong, 2020-10Purchase price allocation; share-based payments
64First Service HoldingReal EstateHong Kong, 2020-10Purchase price allocation
65Zonbong LandscapeEngineeringHong Kong, 2021-01Purchase price allocation; biological assets; available-for-sale assets
66Newlink TechnologyTMTHong Kong, 2021-01Business valuation
67G.H.Y Culture & MediaFilm & MediaSingapore, 2020-12Expected credit loss assessment; purchase price allocation
68Farasis EnergyNew EnergySSE STAR Market, 2020-07Preferred shares; share-based payments
69Immunotech BiopharmPharmaceuticalsHong Kong, 2020-07Equity valuation; preferred equity valuation; employee options
70HepalinkPharmaceuticalsHong Kong, 2020-07Fund financial assets (equity valuation); purchase price allocation; convertible bonds; warrants; share-based payments
71BlueCityTMTNasdaq, 2020-07Purchase price allocation
72QuhuoTMTNasdaq, 2020-07Purchase price allocation; employee options; intangible assets
73Legend BiotechPharmaceuticalsNasdaq, 2020-06Allocation of licensing agreement value
74Hygeia HealthcareHealthcareHong Kong, 2020-06Preferred shares; purchase price allocation; restricted stock; goodwill impairment testing
75WiMi HologramTMTNasdaq, 2020-04Equity valuation
76AnPac BioBiomedicalNasdaq, 2020-01Share-based payments; purchase price allocation; asset impairment testing; equity valuation
77Lizhi FMTMTNasdaq, 2020-01Preferred shares; share-based payments; equity valuation
78Newborn TownTMTHong Kong, 2020-01Purchase price allocation; preferred shares; available-for-sale assets
79PharmaronBiomedicalHong Kong, 2019-11Property valuation
80China FeiheConsumer GoodsHong Kong, 2019-11Financial review and reconciliation
81CMGETMTHong Kong, 2019-10Fund financial assets (equity valuation); convertible bonds; contingent consideration; purchase price allocation; goodwill impairment testing
82Xinyuan PropertyProperty ManagementHong Kong, 2019-10Equity valuation; share-based payments; restricted stock; purchase price allocation; goodwill impairment testing
83EuroEyesHealthcare (Ophthalmology)Hong Kong, 2019-10Equity valuation; purchase price allocation; share-based payments
84JH EducationalEducationHong Kong, 2019-06Property valuation; purchase price allocation; goodwill impairment testing
85China Kepei EducationEducationHong Kong, 2019-01Property valuation; purchase price allocation; goodwill impairment testing; share-based payments
86InkeTMTHong Kong, 2018-07Purchase price allocation; goodwill impairment testing; financial assets; share-based payments
87China New Higher EducationEducationHong Kong, 2017-04Property valuation; purchase price allocation; goodwill impairment testing
88Yuhua EducationEducationHong Kong, 2017-03Property valuation; purchase price allocation; convertible bonds
View Original